Abbott Laboratories
SWB:ABL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abbott Laboratories
SWB:ABL
|
US |
|
Stora Enso Oyj
F:ENU
|
FI |
|
M
|
Mitsubishi Corp
XMUN:MBI
|
JP |
|
G
|
Getinge AB
XMUN:GTN
|
SE |
|
E
|
EssilorLuxottica SA
XMUN:ESL
|
FR |
|
L
|
LATAM Airlines Group SA
SWB:LFL
|
CL |
|
Data I/O Corp
NASDAQ:DAIO
|
US |
|
CGI Inc
F:CJ5A
|
CA |
|
A
|
AMETEK Inc
SWB:AK1
|
US |
|
H
|
Hermes International SCA
DUS:HMI
|
FR |
|
D
|
Dominion Energy Inc
XMUN:DOD
|
US |
|
Trade Desk Inc
BMV:TTD
|
US |
|
I
|
Insperity Inc
F:ASF
|
US |
|
F
|
FedEx Corp
XMUN:FDX
|
US |
Wall St Price Targets
ABL Price Targets Summary
Abbott Laboratories
According to Wall Street analysts, the average 1-year price target for ABL is 104.84 EUR with a low forecast of 80.67 EUR and a high forecast of 123.97 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABL's stock price target?
Price Target
104.84
EUR
According to Wall Street analysts, the average 1-year price target for ABL is 104.84 EUR with a low forecast of 80.67 EUR and a high forecast of 123.97 EUR.
What is the Revenue forecast for Abbott Laboratories?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 10%.
What is the Gross Profit forecast for Abbott Laboratories?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 3 years is 11%.
What is the Operating Income forecast for Abbott Laboratories?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 3 years is 20%.
What is the Pre-Tax Income forecast for Abbott Laboratories?
Projected CAGR
19%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 19%.
What is the Net Income forecast for Abbott Laboratories?
Projected CAGR
22%
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 3 years is 22%.
